These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35223422)

  • 1. Ensuring the business continuity of production companies in conditions of COVID-19 pandemic in Poland - Applied measures analysis.
    Kosieradzka A; Smagowicz J; Szwed C
    Int J Disaster Risk Reduct; 2022 Apr; 72():102863. PubMed ID: 35223422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Effectiveness of Employers and H&S Services in Relation to the COVID-19 System in Polish Manufacturing Companies.
    Bartnicka J; Kabiesz P; Palka D; Gajewska P; Islam EU; Szymanek D
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions reducing tobacco smoking at the workplace--do larger and richer companies solve the problem better?
    Puchalski K; Korzeniowska E
    Med Pr; 2012; 63(3):257-70. PubMed ID: 22880448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Assessment of the SME Sector Operations during the COVID-19 Pandemic.
    Grondys K; Ślusarczyk O; Hussain HI; Androniceanu A
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interest in vaccination against COVID-19 and other pro-health initiatives at the workplace among employees in Poland.
    Olearczyk A; Olejniczak D
    Med Pr; 2021 Dec; 72(6):653-659. PubMed ID: 34889316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation strategies used by companies in Poland during the pandemic.
    Kozioł-Nadolna K
    Procedia Comput Sci; 2022; 207():3198-3207. PubMed ID: 36275375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey.
    Beninger P; Caubel P; Sharma L; Pajovich G; Boyd P
    Clin Ther; 2022 Sep; 44(9):1225-1236. PubMed ID: 35940940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Workplace health promotion in Poland in 2015 - Diagnosis based on a representative survey of companies employing more than 50 employees].
    Puchalski K; Korzeniowska E
    Med Pr; 2017 Mar; 68(2):229-246. PubMed ID: 28345683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onboarding in Polish Enterprises in the Perspective of HR Specialists.
    Krugiełka A; Bartkowiak G; Knap-Stefaniuk A; Sowa-Behtane E; Dachowski R
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].
    Imai T; Moriguchi J; Abe H; Maeda K; Sukegawa M; Shibata E; Nishikido N
    Sangyo Eiseigaku Zasshi; 2022 May; 64(3):137-145. PubMed ID: 34162772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors in the assessment of suppliers.
    Urbaniak M; Zimon D; Madzik P; Šírová E
    PLoS One; 2022; 17(8):e0272157. PubMed ID: 35913910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IMPLICATIONS OF THE FIRST WAVE OF COVID-19 FOR SMALL BUSINESSES: SOCIOLOGICAL ASSESSMENT].
    Tanatova DK; Yudina TN; Dolgorukova IV; Korolev IV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Jun; 29(Special Issue):784-788. PubMed ID: 34327963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Business transformation in an age of turbulence - Lessons learned from COVID-19.
    Li X; Voorneveld M; de Koster R
    Technol Forecast Soc Change; 2022 Mar; 176():121452. PubMed ID: 35001984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Pandemic Residual Risk Assessment Tool for Building Organizational Resilience within Polish Enterprises.
    Ewertowski T; Butlewski M
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34209549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health promotion in enterprises counteracting the consequences of workforce ageing. How does it differ from interventions in other companies and what kind of barriers does it face?].
    Goszczyńska E
    Med Pr; 2020 May; 71(3):289-307. PubMed ID: 32208413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workforce and supply chain disruption as a digital and technological innovation opportunity for resilient manufacturing systems in the COVID-19 pandemic.
    Ambrogio G; Filice L; Longo F; Padovano A
    Comput Ind Eng; 2022 Jul; 169():108158. PubMed ID: 35431410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managerial Perception of Risk in an Organization in a Post-COVID-19 Work Environment.
    Ewertowski T; Butlewski M
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of employers and OHS services during the developing COVID-19 epidemic in Poland.
    Nowacki K; Grabowska S; Łakomy K
    Saf Sci; 2020 Nov; 131():104935. PubMed ID: 32834519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovativeness of Industrial Processing Enterprises and Conjunctural Movement.
    Jakimowicz A; Rzeczkowski D
    Entropy (Basel); 2020 Oct; 22(10):. PubMed ID: 33286946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of COVID-19 control policies for sustainable development of business: Evidence from service industries.
    Chen J; Huang J; Su W; Štreimikienė D; Baležentis T
    Technol Soc; 2021 Aug; 66():101643. PubMed ID: 34898758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.